Drugs Made In America Acquisition Balance Sheet (2024-2025) | DMII

Balance Sheet Dec2024 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 0.02M0.32M223.00
Cash & Current Investments (Quarter) 0.02M0.32M223.00
Receivables - Other (Quarter) 0.57M
Prepaid Assets (Quarter) 0.04M0.01M0.03M
Current Assets (Quarter) 0.06M0.90M0.03M
Non-Current Assets
Long-Term Investments (Quarter) 500.11M504.93M
Other Non-Current Assets (Quarter) 0.08M
Non-Current Assets (Quarter) 0.08M500.11M504.93M
Assets (Quarter) 0.14M501.01M504.96M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.00M0.10M
Notes Payables (Quarter) 0.25M
Payables (Quarter) 0.25M0.00M0.10M
Accumulated Expenses (Quarter) 0.00M0.01M0.09M
Other Accumulated Expenses (Quarter) 0.55M
Total Current Liabilities (Quarter) 0.25M0.68M0.30M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 500.11M504.93M
Total Non-Current Liabilities (Quarter) 17.50M
Total Liabilities (Quarter) 0.25M18.18M17.80M
Shareholder's Equity
Common Equity (Quarter) -0.12M-17.28M-17.77M
Shareholder's Equity (Quarter) -0.12M-17.28M-17.77M
Liabilities and Shareholders Equity (Quarter) 0.14M501.01M504.96M
Retained Earnings (Quarter) -0.15M-17.28M-17.78M